Initial Validation of the Vanderbilt ADHD Measure for Adolescent Patients in the ICISS Project (TriVox Health)
PI: Joshua Borus, MD, MPH
Participants: Children ages 13-21 years with a diagnosis of ADHD
This study aims to assess construct validity by evaluating the degree to which the Vanderbilt measures show convergence with a similar set of ADHD screening tools.
Integrated Clinical Information Sharing System ICISS (TriVox Health): Implementation and evaluation of a web-based patient management and monitoring system for chronic conditions
PI:Eugenia Chan
Participants: All ages, with a diagnosis of ADHD, autism
Evaluation of TriVox Health (formally known as ICISS) including cost effectiveness.
Validating parent entered medication data via ICISS/eDMC (TriVox Health) and assessing the impact of ICISS/eDMC (TriVox Health) on the availability of parent and teacher rating scales at time of visit
PIs: Eugenia Chan, Eric Fleegler
Participants: 3-18 years old with a diagnosis of ADHD
Evaluation of TriVox Health (formally known as ICISS).
